Joy Liu - Apr 29, 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Apr 29, 2022
Transactions value $
-$33,049
Form type
4
Date filed
5/3/2022, 04:28 PM
Previous filing
Feb 28, 2022
Next filing
May 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Sale -$4.65K -17 -0.12% $273.37 14.4K Apr 29, 2022 Direct F1, F2, F3
transaction VRTX Common Stock Sale -$11.3K -41 -0.28% $274.75 14.4K Apr 29, 2022 Direct F1, F2, F4
transaction VRTX Common Stock Sale -$8.27K -30 -0.21% $275.62 14.4K Apr 29, 2022 Direct F1, F2, F5
transaction VRTX Common Stock Sale -$6.09K -22 -0.15% $276.72 14.3K Apr 29, 2022 Direct F1, F2, F6
transaction VRTX Common Stock Sale -$2.78K -10 -0.07% $278.04 14.3K Apr 29, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1.
F2 Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $273.37 (range $273.13 to $273.87).
F4 Open market sales reported on this line occurred at a weighted average price of $274.74 (range $274.20 to $275.14).
F5 Open market sales reported on this line occurred at a weighted average price of $275.62 (range $275.22 to $276.19).
F6 Open market sales reported on this line occurred at a weighted average price of $276.72 (range $276.31 to $277.06).